Literature DB >> 11411014

Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever.

A Yildiz1, V Akkaya, I Kiliçaslan, A Türkmen, B Görçin, D Atilgan, M S Sever.   

Abstract

In Turkey, familial Mediterranean fever (FMF) is an important cause of nephrotic syndrome and endstage renal disease due to renal deposition of AA type amyloid. We report a case of living-related donor renal transplant recipient with FMF and renal AA type amyloidosis, who died of progressive heart failure due to cardiac involvement. The patient also had intractable diarrhea caused by biopsy-proven intestinal amyloidosis. The patient was on 1 mg/day colchicine. Although he was attack-free throughout the post-transplant period, intestinal and clinically significant cardiac amyloidosis, which implied the presence of sustained inflammation and continuing amyloid deposition, appeared three years after renal transplantation. Cardiac deposition of AA amyloid may cause clinically significant heart disease, leading to cardiovascular mortality after renal transplantation for end-stage renal disease in FMF patients.

Entities:  

Mesh:

Year:  2001        PMID: 11411014

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  QT dispersion in amyloidosis due to familial Mediterranean fever.

Authors:  Udi Nussinovitch; Naomi Nussinovitch; Moshe Nussinovitch; Benjamin Volovitz; Olga Feld; Ilan Ben-Zvi; Avi Livneh
Journal:  Rheumatol Int       Date:  2011-04-02       Impact factor: 2.631

Review 2.  Vascular comorbidities in familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Fatoş Yalçınkaya
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

3.  Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.

Authors:  Sahru Yüksel; Lilit Ayvazyan; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 4.  Cardiac disease in familial Mediterranean fever.

Authors:  Eren Erken; Ertugrul Erken
Journal:  Rheumatol Int       Date:  2017-10-20       Impact factor: 2.631

5.  Renal and suprarenal insufficiency secondary to familial Mediterranean fever associated with amyloidosis: a case report.

Authors:  Ahmet Burak Toros; Fusun Erdenen; Nagehan Didem Sari; Serkan Gokcay
Journal:  J Med Case Rep       Date:  2011-08-18

Review 6.  Cardiac manifestations of Familial Mediterranean fever.

Authors:  Ahmad Alsarah; Osama Alsara; Heather S Laird-Fick
Journal:  Avicenna J Med       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.